Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05577312 |
|
Recruitment Status :
Enrolling by invitation
First Posted : October 13, 2022
Last Update Posted : March 4, 2024
|
Sponsor:
Bioray Laboratories
Collaborators:
First Affiliated Hospital of Guangxi Medical University
Xiangya Hospital of Central South University
Chinese Academy of Medical Sciences
Nanfang Hospital, Southern Medical University
Information provided by (Responsible Party):
Bioray Laboratories
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Enrolling by invitation |
|---|---|
| Estimated Primary Completion Date : | August 4, 2025 |
| Estimated Study Completion Date : | September 10, 2026 |